NasdaqCM - Nasdaq Real Time Price USD
Nektar Therapeutics (NKTR)
0.6640
+0.0381
+(6.09%)
At close: April 22 at 4:00:01 PM EDT
0.6799
+0.02
+(2.39%)
After hours: April 22 at 7:16:31 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-175,709
-175,709
-192,606
-304,007
-412,660
Investing Cash Flow
142,570
142,570
139,564
365,835
202,777
Financing Cash Flow
42,118
42,118
30
1,508
36,238
End Cash Position
44,252
44,252
35,277
88,227
25,218
Income Tax Paid Supplemental Data
76
76
2,656
272
325
Capital Expenditure
-1,468
-1,468
-865
-5,676
-14,989
Repurchase of Capital Stock
-3,000
-3,000
--
--
--
Free Cash Flow
-177,177
-177,177
-193,471
-309,683
-427,649
12/31/2021 - 5/3/1994
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
LXEO Lexeo Therapeutics, Inc.
3.4200
+6.54%
CRVS Corvus Pharmaceuticals, Inc.
3.3300
+3.42%
SGMO Sangamo Therapeutics, Inc.
0.7763
+5.48%
MREO Mereo BioPharma Group plc
2.5000
+7.30%
IDYA IDEAYA Biosciences, Inc.
18.63
+2.48%
CYTK Cytokinetics, Incorporated
37.81
-0.32%
SWTX SpringWorks Therapeutics, Inc.
40.50
+9.28%
ACET Adicet Bio, Inc.
0.5817
+2.34%
RZLT Rezolute, Inc.
3.1100
-0.96%
JANX Janux Therapeutics, Inc.
30.01
+2.42%